![OptiNose Inc](/common/images/company/N_OPTN.png)
OptiNose Inc (OPTN)
NASDAQ
The current OPTN market cap is 144.12M. The company's latest EPS is USD -0.3139 and P/E is -4.05.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 11.85M | 19.45M | 19.82M | 19.87M | 14.88M |
Operating Income | -14.37M | -4.17M | -1.69M | -2.51M | -8.08M |
Net Income | -18.85M | 2.62M | -9.29M | -9.97M | -14.07M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 34.63M | 49.12M | 74.65M | 76.28M | 70.99M |
Operating Income | -96M | -87.22M | -66.45M | -55.9M | -22.75M |
Net Income | -110.45M | -99.79M | -82.3M | -74.83M | -35.48M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 114.93M | 106.07M | 101.41M | 107.73M | 83.71M |
Total Liabilities | 188.71M | 175.73M | 179.02M | 194.34M | 182.92M |
Total Equity | -73.79M | -69.66M | -77.62M | -86.61M | -99.22M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 172.65M | 188.81M | 166.07M | 144.22M | 107.73M |
Total Liabilities | 111.07M | 182.03M | 187.84M | 200.85M | 194.34M |
Total Equity | 61.58M | 6.79M | -21.77M | -56.62M | -86.61M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -10.48M | -23.02M | -27.44M | -20.53M | -22.03M |
Investing | N/A | -79k | -255k | -328k | -22k |
Financing | 162k | 162k | 296k | 300k | 7k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -90.82M | -86.21M | -76.94M | -67.65M | -20.53M |
Investing | -557k | -546k | -62k | -63k | -328k |
Financing | 37.53M | 83.81M | 43.32M | 51.44M | 300k |
Market Cap | 144.12M |
Price to Earnings Ratio | -4.05 |
Price to Sales Ratio | 2.02 |
Price to Cash Ratio | 1.95 |
Price to Book Ratio | -1.66 |
Dividend Yield | - |
Shares Outstanding | 113.04M |
Average Volume (1 week) | 675.95k |
Average Volume (1 Month) | 1.3M |
52 Week Change | 38.29% |
52 Week High | 2.10 |
52 Week Low | 0.80 |
Spread (Intraday) | 0.33 (23.91%) |
Company Name | OptiNose Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.optinose.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.